anti-mitotic Eg5 inhibitors (Harvard University/Harvard University Office of Technology Development)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Nameanti-mitotic Eg5 inhibitors (Harvard University/Harvard University Office of Technology Development)
Drug Alias Namedihydropyrancarboxamide compounds (Harvard University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein 1 inhibitors
TargetsKinesin-like protein 1
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarvard University
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A